AGRYLIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Agrylin, and what generic alternatives are available?
Agrylin is a drug marketed by Takeda Pharms Usa and is included in one NDA.
The generic ingredient in AGRYLIN is anagrelide hydrochloride. There are eight drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the anagrelide hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Agrylin
A generic version of AGRYLIN was approved as anagrelide hydrochloride by IMPAX LABS on April 18th, 2005.
Summary for AGRYLIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 101 |
Clinical Trials: | 3 |
Patent Applications: | 787 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for AGRYLIN |
What excipients (inactive ingredients) are in AGRYLIN? | AGRYLIN excipients list |
DailyMed Link: | AGRYLIN at DailyMed |
Recent Clinical Trials for AGRYLIN
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shire | Phase 3 |
Mylan Pharmaceuticals | Phase 1 |
Pharmacology for AGRYLIN
Drug Class | Platelet-reducing Agent |
Mechanism of Action | Phosphodiesterase 3 Inhibitors |
Physiological Effect | Decreased Platelet Production |
Anatomical Therapeutic Chemical (ATC) Classes for AGRYLIN
US Patents and Regulatory Information for AGRYLIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Takeda Pharms Usa | AGRYLIN | anagrelide hydrochloride | CAPSULE;ORAL | 020333-001 | Mar 14, 1997 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
Takeda Pharms Usa | AGRYLIN | anagrelide hydrochloride | CAPSULE;ORAL | 020333-002 | Mar 14, 1997 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |